longbridge

Liminatus Pharma

LIMN
----

All Shareholders

Shareholder Type

  • Public and others74.77%
  • Individuals & Insiders12.21%
  • Public companies6.51%
  • Private companies5.10%
  • Institutions1.41%

Major Shareholders

Major Shareholders Latest
Shareholder
Chris KimCEO, Chairman & President
7.81%104.89K4.60%+68.97K
HMNEX Co., Ltd.
6.51%87.47K1.30%+0
Samda Biolab Co., Ltd.
5.10%68.53K--+68.53K
Mary Song
2.19%29.40K1.09%+0
Kyung Hyun
2.19%29.40K1.09%+0
Cygnus Capital Advisors, LLC
0.49%6.59K0.29%-414.00
XTX Markets Limited
0.33%4.44K--+4.44K
Geode Capital Management, LLC
0.21%2.77K0.06%+413.00
Vanguard Capital Management, LLC
0.11%1.47K0.05%+0
Citadel Advisors LLC
0.08%1.12K1.43%-12.43K
The Goldman Sachs Group, Inc.
0.06%804.00--+804.00
Sterne Agee Asset Management, Inc.
0.04%521.00--+521.00
State Street Investment Management
0.03%380.000.01%+0
UBS Asset Management AG
0.02%334.000.10%-757.00
Nicholas FernandezIndependent Director
0.02%333.00<0.01%+0
Vanguard Personalized Indexing Management
0.02%262.000.06%-432.00
Tower Research Capital Europe Limited
0.01%141.00<0.01%-10.00
Barclays Bank Plc
<0.01%85.00--+85.00
BlackRock, Inc.
<0.01%6.000.03%-259.00
KH Feelux Co., Ltd.
0.00%0.004.76%-53.33K
© 2026 Longbridge｜Terms of ServicePrivacy Policy